Re: BioSig to Participate in the Benzinga All Access Event on December 14, 2021
The biographical information on the company website indicates that Natasha Drapeau, the company presenter on Dec 14th, is in her fourth year with BSGM, is UK-educated, based in Switzerland and she has experience in developing business strategies.
Therefore I expect to hear that the "strategic initiatives" are about their entry into Europe since BioSig remains undercapitalized as a microcap startup. The US empirical data generated thus far should be enough to invite a paying partner to share the returns from a key market. Ideally, imo, signing three to separately serve the UK, France and Germany would be smart for a first year beginning. I suspect Ms. Drapeau has a plan.